甲状旁腺激素相关蛋白(PTHrP)多克隆抗体

Polyclonal Antibody to Parathyroid Hormone Related Protein (PTHrP)

PTHLH; HHM; PTHR; PLP; Osteostatin; Parathyroid Hormone Like Hormone

  • 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 IHC图
  • PAA819Mu01.jpg Figure. Western Blot; Sample: Recombinant PTHrP, Mouse.
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对PTHrP的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别PTHrP。

用法

Western blotting: 0.5-2µg/mL;1:230-900
Immunohistochemistry: 5-20µg/mL;1:23-90
Immunocytochemistry: 5-20µg/mL;1:23-90
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPA819Mu01 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA819Mu02 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA819Mu01 甲状旁腺激素相关蛋白(PTHrP)活性蛋白 Cell culture; Activity Assays.
CPA819Mu21 甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA819Mu22 甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA819Mu31 甲状旁腺激素相关蛋白(PTHrP)钥孔血蓝蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAA819Mu01 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 WB; IHC; ICC; IP.
PAA819Mu02 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 WB; IHC; ICC; IP.
PAA819Mu08 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 WB; IHC; ICC; IP.
SEA819Mu 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA819Mu 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
KSA819Mu11 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Clinical and Experimental Metastasis Characterization of a new renal cell carcinoma bone metastasis mouse model [PubMed: 20443133]
Stem Cells and Development Temporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated. [PubMed: 22133004]
International journal of biological sciences PTHrP Expression in Human MDA-MB-231 Breast Cancer Cells Is Critical for Tumor Growth and Survival and Osteoblast Inhibition [PubMed: PMC3753447]
Investigational New Drugs Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts [Pubmed: 23673814]
Toxicology and Applied Pharmacology Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment [Pubmed:24463094]
Arch Gynecol Obstet. Calcitonin gene-and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study [Pubmed:24943060]
PLoS One 15-Deoxy-Δ12, 14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss [PubMed: 25859665]
Endocrinology A role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis [PubMed: 26135836]
Tumour Biol Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation. [Pubmed:27312487]
Cell Death and Differentiation Hedgehog signaling in bone regulates whole-body energy metabolism through a bone–adipose endocrine relay mediated by PTHrP and adiponectin [pubmed:27740628]
留言咨询